These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 14558437

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O, Alvarez JC.
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [Abstract] [Full Text] [Related]

  • 4. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA.
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
    Estevez-Carrizo FE, Parrillo S, Ercoli MC, Estevez-Parrillo FT.
    Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
    Fuchs WS, Weiss G, Von Nieciecki A, Laicher A, Gay S, Pabst G, Müller M.
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
    [Abstract] [Full Text] [Related]

  • 8. [In vivo verification of in vitro release specifications of a theophylline sustained-release preparation].
    von Nieciecki A, Fuchs WS, Pabst G, Müller M, Dilger C, Gay S, Laicher A, Stanislaus F.
    Arzneimittelforschung; 1998 May; 48(5A):580-3. PubMed ID: 9676348
    [Abstract] [Full Text] [Related]

  • 9. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY, Park JH, Park YS, Lee MH, Kim DS, Shaw LM, Yang SC, Kang JS.
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M, Pervaiz F.
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bioequivalence of immediate-release theophylline capsules.
    Meyer MC, Jarvi EJ, Straughn AB, Pelsor FR, Williams RL, Shah VP.
    Biopharm Drug Dispos; 1999 Dec; 20(9):417-9. PubMed ID: 10951430
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
    Steinijans VW, Sauter R, Böhm A, Staudinger H.
    Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
    [Abstract] [Full Text] [Related]

  • 19. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers.
    Palma-Aguirre JA, Lopez-Gamboa M, Cariño L, Burke-Fraga V, González-de la Parra M.
    Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M, Khuroo A, Batolar LS, Tandon M, Monif T, Sharma PL.
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.